GSK-2606414

GSK-2606414
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-1201-M001 1 mg -

3 - 9 business days*

119.00€
SYN-1201-M005 5 mg -

3 - 9 business days*

211.00€
SYN-1201-M010 10 mg -

3 - 9 business days*

329.00€
SYN-1201-M050 50 mg -

3 - 9 business days*

909.00€
SYN-1201-M100 100 mg -

3 - 9 business days*

-
 
Soluble in DMSO or ethanol. GSK2606414 is an orally available, potent, and selective PERK... more
Product information "GSK-2606414"
Soluble in DMSO or ethanol. GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC(50) of 0.4nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed Target: PERK , Kinase Group: Other , Substrate: Serine-Threonine
Keywords: GSK-2606414
Supplier: SYNkinase
Supplier-Nr: 1201

Properties

Application: EIF2AK3 / PERK inhibitor
MW: 451,4 D
Formula: C24H20F3N5O
Purity: >95%
Format: Solid

Database Information

CAS : 1337531-36-8| Matching products
KEGG ID : K08860 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK-2606414"
Write a review
or to review a product.
Viewed